| Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination |
77 |
| Neurofilament light chain as a biomarker in neurological disorders |
61 |
| Neurofilament light chain in serum for the diagnosis of amyotrophic lateral sclerosis |
40 |
| Emotional processing in functional neurological disorder: a review, biopsychosocial model and research agenda |
39 |
| Idiopathic intracranial hypertension: consensus guidelines on management |
38 |
| LGI CASPR2 and related antibodies: a molecular evolution of the phenotypes |
31 |
| Short delay to initiate plasma exchange is the strongest predictor of outcome in severe attacks of NMO spectrum disorders |
29 |
| Hypermetabolism in ALS is associated with greater functional decline and shorter survival |
27 |
| Intensive upper limb neurorehabilitation in chronic stroke: outcomes from the Queen Square programme |
26 |
| Disease-modifying drugs for multiple sclerosis and infection risk: a cohort study |
25 |
| Developing and validating Parkinson's disease subtypes and their motor and cognitive progression |
24 |
| A unifying theory for cognitive abnormalities in functional neurological disorders, fibromyalgia and chronic fatigue syndrome: systematic review |
24 |
| Vascular pathology in multiple sclerosis: reframing pathogenesis around the blood-brain barrier |
23 |
| Accuracy of clinical diagnosis of dementia with Lewy bodies: a systematic review and meta-analysis |
23 |
| Inflammatory markers in Alzheimer's disease and mild cognitive impairment: a meta-analysis and systematic review of 170 studies |
22 |
| Evidence for cannabis and cannabinoids for epilepsy: a systematic review of controlled and observational evidence |
22 |
| Controversy of posterior reversible encephalopathy syndrome: what have we learnt in the last 20 years? |
22 |
| Pathogenesis of dystonia: is it of cerebellar or basal ganglia origin? |
21 |
| Clinical and immunological characteristics of the spectrum of GFAP autoimmunity: a case series of 22 patients |
21 |
| Systematic review and meta-analysis on outcome differences among patients with TICI2b versus TICI3 reperfusions: success revisited |
21 |
| Marriage and risk of dementia: systematic review and meta-analysis of observational studies |
21 |
| Different neuroinflammatory profile in amyotrophic lateral sclerosis and frontotemporal dementia is linked to the clinical phase |
20 |
| CSF cytokine profile in MOG-IgG plus neurological disease is similar to AQP4-IgG+ NMOSD but distinct from MS: a cross-sectional study and potential therapeutic implications |
20 |
| Atypical CIDP: diagnostic criteria, progression and treatment response. Data from the Italian CIDP Database |
20 |
| Image-based analysis and long-term clinical outcomes of deep brain stimulation for Tourette syndrome: a multisite study |
19 |
| Features of GBA-associated Parkinson's disease at presentation in the UK Tracking Parkinson's study |
19 |
| Peripheral inflammation in prodromal Alzheimer's and Lewy body dementias |
18 |
| Awake versus asleep deep brain stimulation for Parkinson's disease: a critical comparison and meta-analysis |
18 |
| Retinal ganglion cell loss in neuromyelitis optica: a longitudinal study |
18 |
| Inflammatory markers in cerebrospinal fluid: independent prognostic biomarkers in amyotrophic lateral sclerosis? |
18 |
| Transcranial magnetic stimulation predicts cognitive decline in patients with Alzheimer's disease |
17 |
| Stress and functional neurological disorders: mechanistic insights |
17 |
| Chitotriosidase (CHIT1) is increased in microglia and macrophages in spinal cord of amyotrophic lateral sclerosis and cerebrospinal fluid levels correlate with disease severity and progression |
17 |
| Outcomes from stereotactic surgery for essential tremor |
17 |
| Pathophysiological and cognitive mechanisms of fatigue in multiple sclerosis |
16 |
| Prospective phase II clinical trial of autologous haematopoietic stem cell transplant for treatment refractory multiple sclerosis |
16 |
| Prospective, multicentre study of external ventricular drainage-related infections in the UK and Ireland |
16 |
| Neurofilament light chain and tau concentrations are markedly increased in the serum of patients with sporadic Creutzfeldt-Jakob disease, and tau correlates with rate of disease progression |
16 |
| Models for predicting risk of dementia: a systematic review |
16 |
| Misfolded SOD1 inclusions in patients with mutations in C9orf72 and other ALS/FTD-associated genes |
16 |
| Efficacy of intensive multidisciplinary rehabilitation in Parkinson's disease: a randomised controlled study |
16 |
| Baseline prevalence and longitudinal evolution of non-motor symptoms in early Parkinson's disease: the PPMI cohort |
15 |
| Orthostatic hypotension and REM sleep behaviour disorder: impact on clinical outcomes in alpha-synucleinopathies |
15 |
| Challenges in modelling the Charcot-Marie-Tooth neuropathies for therapy development |
15 |
| Imaging and CSF analyses effectively distinguish CJD from its mimics |
14 |
| Complex regional pain syndrome and functional neurological disorders - time for reconciliation |
14 |
| Imaging the pathoanatomy of amyotrophic lateral sclerosis in vivo: targeting a propagation-based biological marker |
14 |
| Recent advances in neuropathology, biomarkers and therapeutic approach of multiple system atrophy |
14 |
| Flortaucipir tau PET imaging in semantic variant primary progressive aphasia |
14 |
| [F-18]AV-1451 binding in vivo mirrors the expected distribution of TDP-43 pathology in the semantic variant of primary progressive aphasia |
14 |
